Therapeutic combination by T cells with anti-CD19 and anti-chimeric antigen receptors for maturation of relapsed or refractory multiple myeloma B cells

被引：0
|
作者：
Stocker, Nicolas
机构：
来源：
HEMATOLOGIE | 2019年 / 25卷 / 06期
关键词：
D O I：
10.1684/hma.2019.1502
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [31] Infusion of chimeric antigen receptor T cells against dual targets of CD19 and B-cell maturation antigen for the treatment of refractory multiple myeloma
    Tang, Fang
    Lu, Yin
    Ge, Yongqin
    Shang, Jingjing
    Zhu, Xiaming
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (01)
  • [32] Safety and efficacy of anti-CD19 chimeric antigen receptor (CAR)-modified autologous T cells (CTL019) in advanced multiple myeloma.
    Garfall, Alfred L.
    Maus, Marcela Valderrama
    Lacey, Simon F.
    Mahnke, Yolanda D.
    Melenhorst, Jan J.
    Zheng, Zhaohui
    Vogl, Dan T.
    Cohen, Adam D.
    Weiss, Brendan M.
    Dengel, Karen
    Kerr, Naseem D. S.
    Hwang, Wei-Ting
    Levine, Bruce
    June, Carl H.
    Stadtmauer, Edward Allen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Results of a phase I study of bispecific anti-CD19, anti-CD20 chimeric antigen receptor (CAR) modified T cells for relapsed, refractory, non-Hodgkin lymphoma.
    Shah, Nirav Niranjan
    Zhu, Fenlu
    Schneider, Dina
    Taylor, Carolyn
    Krueger, Winfried
    Worden, Andrew
    Longo, Walter L.
    Hamadani, Mehdi
    Fenske, Timothy
    Johnson, Bryon
    Dropulic, Boro
    Orentas, Rimas
    Hari, Parameswaran
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies
    Ruella, Marco
    Barrett, David M.
    Kenderian, Saad S.
    Shestova, Olga
    Hofmann, Ted J.
    Scholler, John
    Lacey, Simon F.
    Melenhorst, J. Joseph
    Nazimuddin, Farzana
    Perazzelli, Jessica
    Christian, David A.
    Hunter, Christopher A.
    Porter, David L.
    June, Carl H.
    Grupp, Stephan A.
    Gill, Saar I.
    BLOOD, 2015, 126 (23)
  • [35] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Gu, Runxia
    Liu, Fang
    Zou, Dehui
    Xu, Yingxi
    Lu, Yang
    Liu, Bingcheng
    Liu, Wei
    Chen, Xiaojuan
    Liu, Kaiqi
    Guo, Ye
    Gong, Xiaoyuan
    Lv, Rui
    Chen, Xia
    Zhou, Chunlin
    Zhong, Mengjun
    Wang, Huijun
    Wei, Hui
    Mi, Yingchang
    Qiu, Lugui
    Lv, Lulu
    Wang, Min
    Wang, Ying
    Zhu, Xiaofan
    Wang, Jianxiang
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [36] Decitabine enhances cytotoxic effect of T cells with an anti-CD19 chimeric antigen receptor in treatment of lymphoma
    Li, Sujun
    Xue, Lei
    Wang, Min
    Qiang, Ping
    Xu, Hui
    Zhang, Xuhan
    Kang, Wenyao
    You, Fengtao
    Xu, Hanying
    Wang, Yu
    Liu, Xin
    Yang, Lin
    Wang, Xingbing
    ONCOTARGETS AND THERAPY, 2019, 12 : 5627 - 5638
  • [37] Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL
    Rossi, John
    Paczkowski, Patrick
    Shen, Yueh-Wei
    Morse, Kevin
    Flynn, Brianna
    Kaiser, Alaina
    Ng, Colin
    Gallatin, Kyle
    Cain, Tom
    Fan, Rong
    Mackay, Sean
    Heath, James R.
    Rosenberg, Steven A.
    Kochenderfer, James N.
    Zhou, Jing
    Bot, Adrian
    BLOOD, 2018, 132 (08) : 804 - 814
  • [38] Anti-CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
    Li, Mengtao
    Zhang, Yan
    Jiang, Nan
    Ning, Chun
    Wang, Qian
    Xu, Dong
    Wang, Ziqian
    Lv, Lulu
    Zhou, Daobin
    Zeng, Xiaofeng
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (04): : 376 - 378
  • [39] Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells
    Morita, Daisuke
    Nishio, Nobuhiro
    Saito, Shoji
    Tanaka, Miyuki
    Kawashima, Nozomu
    Okuno, Yusuke
    Suzuki, Satoshi
    Matsuda, Kazuyuki
    Maeda, Yasuhiro
    Wilson, Matthew H.
    Dotti, Gianpietro
    Rooney, Cliona M.
    Takahashi, Yoshiyuki
    Nakazawa, Yozo
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2018, 8 : 131 - 140
  • [40] Preclinical development of a new type of anti-CD19 chimeric antigen receptor T cells (ARI-0001 cells)
    Castella, Maria
    Boronat, Anna
    Martin-Ibanez, Raquel
    Rodriguez, Vanina
    Caballero, Miguel
    Marzal, Berta
    Castano, Julio
    Bueno, Clara
    Balague, Olga
    Benitez, Daniel
    Ortiz-Maldonado, Valentin
    Baumann, Tycho
    Campo, Elias
    Menendez, Pablo
    Rives, Susana
    Delgado, Julio
    Yague, Jordi
    Perez-Galan, Patricia
    Maria Canals, Josep
    Urbano-Ispizua, Alvaro
    Juan, Manel
    BONE MARROW TRANSPLANTATION, 2018, 53 : 675 - 676
12345